Rua Bioscience Limited (NZE:RUA)

Market Cap	10.14M
Revenue (ttm)	1.06M
Net Income (ttm)	-4.67M
Shares Out	225.35M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,810
Average Volume	132,415
Open	0.0430
Previous Close	0.0420
Day's Range	0.0430 - 0.0460
52-Week Range	0.0230 - 0.0491
Beta	0.30
RSI	70.00
Earnings Date	Aug 29, 2025

About Rua Bioscience

Rua Bioscience Limited engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally. The company offers cannabinoid derived medicines. It is also involved in seed production and genetic discovery related activities. In addition, the company engages in plant breeding business, as well as involved in plant research activities. Rua Bioscience Limited was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. The company was founde...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: New Zealand
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: RUA

Financial Performance

In 2024, Rua Bioscience's revenue was 316,350, a decrease of -52.68% compared to the previous year's 668,484. Losses were -13.72 million, 130.2% more than in 2023.